VIZIMPRO FDA approval date

The FDA approved VIZIMPRO on 27 Sep 2018.

FDA approval date
27 Sep 2018

Drug identity has not yet been verified against registry records

Also recorded as DACOMITINIB

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2018-09-27DayVIZIMPROFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA211288", "applicant_as_listed_by_fda": "PFIZER", "brand_names": ["VIZIMPRO"], "active_ingredients": ["DACOMITINIB"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20180927", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026